FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 107 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q2 2022. The put-call ratio across all filers is 6.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $37,641,000 | +169.8% | 1,886,760 | -6.8% | 0.25% | +212.7% |
Q2 2022 | $13,951,000 | -25.9% | 2,024,876 | 0.0% | 0.08% | -26.9% |
Q1 2022 | $18,831,000 | -34.6% | 2,024,876 | 0.0% | 0.11% | -22.9% |
Q4 2021 | $28,794,000 | -38.7% | 2,024,876 | 0.0% | 0.14% | -32.0% |
Q3 2021 | $46,957,000 | -6.8% | 2,024,876 | 0.0% | 0.21% | -6.8% |
Q2 2021 | $50,399,000 | -11.2% | 2,024,876 | 0.0% | 0.22% | -10.2% |
Q1 2021 | $56,737,000 | -19.7% | 2,024,876 | 0.0% | 0.25% | -7.5% |
Q4 2020 | $70,668,000 | -20.0% | 2,024,876 | +14.3% | 0.27% | -24.6% |
Q3 2020 | $88,292,000 | -5.0% | 1,771,509 | -11.4% | 0.35% | -13.9% |
Q2 2020 | $92,980,000 | – | 2,000,000 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EDBI Pte Ltd | 1,268,805 | $18,042,000 | 9.80% |
Samsara BioCapital, LLC | 1,565,526 | $22,262,000 | 4.32% |
Cormorant Asset Management, LP | 4,639,995 | $65,981,000 | 3.92% |
Logos Global Management LP | 1,600,000 | $22,752,000 | 2.35% |
RA Capital Management | 9,011,651 | $128,146,000 | 2.26% |
HighVista Strategies LLC | 40,612 | $578,000 | 0.46% |
ARMISTICE CAPITAL, LLC | 1,856,000 | $26,392,000 | 0.43% |
Artal Group S.A. | 1,000,000 | $14,220,000 | 0.39% |
Parkman Healthcare Partners LLC | 100,000 | $1,422,000 | 0.31% |
Integral Health Asset Management, LLC | 75,000 | $1,067,000 | 0.30% |